microdosing glp 1 dose of GLP-1's / Wellness Services / Services How microdosing GLP-1 drugs became

Studies have found GLP-1 receptors in the kidney itself.3 The protective effects include: reducing inflammation in kidney tissue, lowering blood pressure (by about 5-7 mmHg), improving how kidneys filter blood, and reducing protein leakage into urine an early warning sign of kidney damage.4 THE BIGGER PICTURE: 85,000+ PATIENTS A major meta-analysis of 11 clinical trials with 85,373 patients confirmed the kidney benefits

Research shows that most people re-gain at least a portion of their weight back after discontinuing the medication

If you often forget injections or struggle with site rotation, medication management becomes essential

1 Over the past few months, we have also received event reports in the Pennsylvania Patient Safety Reporting System (PA-PSRS) involving complications resulting from GLP-1 agonists not being discontinued prior to a procedure, including one that resulted in aspiration pneumonitis

According to the American Diabetes Association Standards of Care, GLP-1 receptor agonists produce weight loss through multiple mechanisms including central appetite regulation and delayed gastric emptying, beyond gastrointestinal side effects alone

February 17, 2024